Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Mothers and newborns with dental fillings have higher mercury in their hair, but adding fillings during pregnancy doesn't raise mercury levels further.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Penicillamine can cause taste problems due to copper loss, which can be fixed with copper or zinc supplements.

Finasteride harms invertebrates' survival and burial ability.

Hair loss may increase heart disease risk.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

DA-MeHA hydrogel effectively aids stem cell-based skin regeneration.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document explains how to identify different hair problems using a microscope.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Injectable skin boosters effectively rejuvenate aging skin by improving hydration and elasticity.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.